Table 3.
Evaluation of the binding free energies (kJ/mol)) and energy components (kJ/mol)) in the SARS-CoV-2-RBD/drug complexes.
Name drug |
ΔEvdwa | ΔEeleb | ΔGpolc | ΔGnonpold | ΔGbinde |
---|---|---|---|---|---|
Diammonium Glycyrrhizinate |
−201.495 | −11.734 | 44.418 | −14.418 | −182.900 |
Digitoxin | −192.755 | −1.784 | 76.812 | −16.042 | −133.789 |
Ivermectin | −131.07 | −3.956 | 53.812 | −8.146 | −89.360 |
aEvdw, van der Waals contribution; bΔEele, electrostatic contribution; cΔGpol, polar solvation energy; dΔGnonpol, nonpolar solvation energy; eΔGbind, binding energy; ΔGbind = ΔEvdw + ΔEele + ΔGpol + ΔGnonpol.